• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

BioGaia

120.20 SEK

-1.48 %

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.48 %
-2.51 %
+2.82 %
+14.48 %
+13.18 %
+13.72 %
+3.62 %
+22.53 %
+1,592.17 %

BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.

Read more
Market cap
12.16B SEK
Turnover
5.86M SEK
Revenue
1.54B
EBIT %
26.82 %
P/E
36.53
Dividend yield-%
3.33 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
17/7
2026

Interim report Q2'26

22/10
2026

Interim report Q3'26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

BioGaia, Audiocast, Q2'26
Webcast2026-07-17 09:30

BioGaia, Audiocast, Q2'26

BioGaia
Regulatory press release2026-05-07 18:00

Bulletin from Annual General Meeting of BioGaia AB (publ)

BioGaia
Regulatory press release2026-05-07 18:00

Kommuniké från årsstämma i BioGaia

BioGaia

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
BioGaia, Audiocast, Q1'26
Webcast2026-05-07 09:30

BioGaia, Audiocast, Q1'26

BioGaia
Regulatory press release2026-05-07 08:00

BioGaia AB: Delårsredogörelse januari - mars 2026

BioGaia
Regulatory press release2026-05-07 08:00

BioGaia AB: Interim Management Statement January - March 2026

BioGaia
Regulatory press release2026-03-30 15:00

Notice to attend the Annual General Meeting of BioGaia AB (publ)

BioGaia
Regulatory press release2026-03-30 15:00

Kallelse till årsstämma i BioGaia AB (publ)

BioGaia
Regulatory press release2026-03-30 11:00

BioGaias Års- och hållbarhetsredovisning 2025 publicerad

BioGaia
Regulatory press release2026-03-30 11:00

BioGaia Annual and Sustainability Report 2025 published

BioGaia
Press release2026-03-17 13:00

BioGaia utnyttjar option att förvärva återstående aktier i Nutraceutics

BioGaia
Press release2026-03-17 13:00

BioGaia exercises option to acquire remaining shares in Nutraceutics

BioGaia
BioGaia, Audiocast, Q4'25
Webcast2026-02-12 09:30

BioGaia, Audiocast, Q4'25

BioGaia
Regulatory press release2026-02-12 08:00

BioGaia AB: Bokslutskommuniké januari - december 2025

BioGaia
Regulatory press release2026-02-12 08:00

BioGaia AB: Year-end report January - December 2025

BioGaia
Regulatory press release2026-02-03 08:00

BioGaia's results for the fourth quarter to exceed market expectations

BioGaia
Regulatory press release2026-02-03 08:00

BioGaias resultat för fjärde kvartalet överstiger marknadens förväntningar

BioGaia
Regulatory press release2025-12-23 09:07

Finansinspektionen: Flaggningsmeddelande i BioGaia AB

BioGaia
BioGaia, Audiocast, Q3'25
Webcast2025-10-22 09:30

BioGaia, Audiocast, Q3'25

BioGaia
Regulatory press release2025-10-22 08:00

BioGaia AB: Delårsredogörelse januari - september 2025

BioGaia